Assay to identify inhibitors among the possible fluorescent artifacts from the primary HTS inhibition assay of Matrix Metalloproteinase 13 (MMP13) activity This assay used Excitation filter 340 +/- 30 nm, Emission 450 +/- 10 nm Viewlux filter set. 2.5 microliters of substrate solution containing 8 micromolar MMP-13 substrate in Assay Buffer (50 millimolar Tris-HCl, 100 millimolar NaCl, 0.05% v/v Brij-35, 10 millimolar CaCl2, pH 7.5) were dispensed into a 1536 microtiter plate. 20 nanoliters of test compound or positive and negative control (2 millimolar MMP-13 inhibitor and DMSO, respectively) were then added to the appropriate wells. The enzymatic reaction was started by dispensing 2.5 microliters of 2.66 nanomolar MMP-13 in Assay Buffer (same composition as above). Fluorescence was read a first time (t0) after enzyme addition on a Perkin-Elmer Viewlux microplate reader (excitation = 325nm, emission = 450nm). After 4 hours of incubation at 25 degrees Celsius, fluorescence was read a second time (t4). The percent inhibition for each well was then calculated as follows: Percent inhibition = (test_compound_delta RFU - negative_control_ delta RFU)/( positive_control_ delta RFU - negative_control_ delta RFU)*100 Where positive_control is defined as test wells containing 8 micromolar MMP13 inhibitor and negative_control is defined as test wells containing DMSO only. A mathematical algorithm was used to determine nominally inhibitory compounds in the confirmation screen. Two values were calculated: (1) the average percent inhibition of all compounds tested, and (2) three times their standard deviation. The sum of these two values was used as a cutoff parameter, i.e. any compound that exhibited greater %inhibition than the cutoff parameter was declared active. Also, an average and a standard deviation of three replicates were calculated. The reported Pubchem_Activity_Score has been normalized to 100% of the highest observed primary inhibition. Negative % inhibition values are reported as activity score zero. Reagents list: MMP13 enzyme (R&D Systems cat# 511-MM-010, Minneapolis, MN) MMP13 substrate (provided by Prof. G.B. Fields, Florida Atlantic University) MMP13 inhibitor (EMD Biosciences cat# 444283, San Diego, CA) EDTA Disodium salt solution 0.5M (Sigma-Aldrich cat# E7889-100mL, St.Louis, MO) Brij35 30% solution (Sigma-Aldrich cat# B4184-100mL, St.Louis, MO) NaCl (Sigma-Aldrich cat# S3014-500g, St.Louis, MO) CaCl2 (Sigma-Aldrich cat# C8106-500g, St.Louis, MO) Tris-HCl (Fluka cat# 93363-100g, St.Louis, MO)
bao:BAO_0000541 "570" ; # "is counter assay of" -> "570"
bao:BAO_0000812 "1931" ; # "has summary assay" -> "1931"
bao:BAO_0000210 bao:BAO_0000032 ; # "has assay stage" -> "secondary assay"
bao:BAO_0001086 bao:BAO_0000684 ; # "has physicochemical profiling assay" -> "physicochemical profiling assay"
bao:BAO_0000205 bao:BAO_0000217 ; # "has assay format" -> "biochemical format"
bao:BAO_0000205 bao:BAO_0000224 ; # "has assay format" -> "protein format"
bao:BAO_0000205 bao:BAO_0000357 ; # "has assay format" -> "single protein format"
bao:BAO_0000409 bao:BAO_0000411 ; # "assay measurement type" -> "kinetic assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000222 ; # "has participant" -> "generic hydrolase" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 "hydrolase activity assay" ; # "is bioassay type of" -> "hydrolase activity assay"
bao:BAO_0000212 bao:BAO_0000124 ; # "has assay method" -> "enzyme activity measurement method"
bao:BAO_0000212 bao:BAO_0000139 ; # "has assay method" -> "direct enzyme activity measurement method"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> bao:BAO_0000484 ; # "has assay design method" -> "enzyme inhibition"
bao:BAO_0000207 bao:BAO_0000001 ; # "has detection method" -> "fluorescence resonance energy transfer"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "To screen for inhibitors of Matrix Metalloproteinase 13 (MMP13) activity." ; # "screening campaign name" -> "To screen for inhibitors of Matrix Metalloproteinase 13 (MMP13) activity."
bao:BAO_0002853 "Assay to identify inhibitors among the possible fluorescent artifacts from the primary HTS inhibition assay of Matrix Metalloproteinase 13 (MMP13) activity" ; # "has assay title" -> "Assay to identify inhibitors among the possible fluorescent artifacts from the primary HTS inhibition assay of Matrix Metalloproteinase 13 (MMP13) activity"
bao:BAO_0002867 bao:BAO_0000516 ; # "has assay footprint" -> "1536 well plate"
bao:BAO_0002863 bao:BAO_0000536 ; # "has concentration throughput" -> "single concentration"
bao:BAO_0000109 "25 degree celsius" ; # "has temperature value" -> "25 degree celsius"
bao:BAO_0002833 "4 hour" ; # "has incubation time value" -> "4 hour"
bao:BA0_0090012 "\"MMP-13 inhibitor (Pyrimidine-4,6-dicarboxylic acid, bis-(4-fluoro-3-methyl-benzylamide)/Calbiochem cat# 444283))\"" ; # "has participant" -> ""MMP-13 inhibitor (Pyrimidine-4,6-dicarboxylic acid, bis-(4-fluoro-3-methyl-benzylamide)/Calbiochem cat# 444283))""
bao:BAO_0000740 bao:BAO_0000080 ; # "has assay control" -> "positive control"
bao:BA0_0090012 bao:BAO_0000118 ; # "has participant" -> "DMSO"
bao:BAO_0000740 bao:BAO_0000079 ; # "has assay control" -> "negative control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Florida Atlantic University" ; # "material entity assay provider" -> "Florida Atlantic University" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000372 ; # "has assay phase characteristic" -> "homogeneous phase"
bao:BA0_0090012 bao:BAO_0000694 ; # "has participant" -> "Tris" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35225> ; # "has role" -> "buffer"
bao:BA0_0090012 bao:BAO_0000867 ; # "has participant" -> "Brij-35" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_27780> ; # "has role" -> "detergent"
bao:BAO_0002000 bao:BAO_0001003 ; # "has measured entity" -> "pyrimidine-4,6-dicarboxylic acid" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35222> ; # "has role" -> "inhibitor"
bao:BA0_0090012 bao:BAO_0000912 ; # "has participant" -> "Fluorogenic triple-helical peptide 3" || bao:BAO_0003102 bao:BAO_00020143 ; # "has role" -> "substrate"
bao:BA0_0090012 "Matrix metalloproteinase 13 preproprotein variant" ; # "has participant" -> "Matrix metalloproteinase 13 preproprotein variant"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Q53H33" ; # "uniprot ID" -> "Q53H33"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BA0_0090012 "(7-methoxycoumarin-4-yl)acetyl fluorophore" ; # "has participant" -> "(7-methoxycoumarin-4-yl)acetyl fluorophore"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0002865 bao:BAO_0000691 ; # "uses detection instrument" -> "ViewLux ultraHTS Microplate Imager"
bao:BAO_0000737 bao:BAO_0000297 ; # "has manufacturer" -> "Perkin Elmer" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "325 nanometer" ; # "has excitation wavelength value" -> "325 nanometer"
bao:BAO_0002918 "450 nanometer" ; # "has emission wavelength value" -> "450 nanometer"
bao:BAO_0000337 bao:BAO_0000201 ; # "has percent response" -> "percent inhibition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2" ; # "PubChem TID" -> "2"
bao:BAO_0000182 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has response unit" -> "percent"
bao:BAO_0002666 "4" ; # "has concentration value" -> "4"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
bao:BAO_0002787 "1" ; # "has concentration-point number" -> "1"
bao:BAO_0002845 "3" ; # "has repetition point-number" -> "3"
bao:BAO_0000196 bao:BAO_0000091 ; # "has mode of action" -> "inhibition"
bao:BAO_0002864 bao:BAO_0000533 ; # "has repetition throughput" -> "multiple repetition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "kunie" ; # "Annotated by" -> "kunie"
